Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Genetic screen for monitoring hepatitis C virus NS3 serine protease activity.
Reduced fitness of HIV-1 resistant to CXCR4 antagonists.
Influence of human immunodeficiency virus type 1 subtype on mother-to-child transmission.
Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study.
Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity.
RNA interference of HIV replication.
Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation.
Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.
Preferential attachment of HIV particles to activated and CD45RO+CD4+ T cells.